\begingroup\fontsize{7}{9}\selectfont

\begin{longtable}[t]{llcccccccccc}
\toprule[0.5pt]
\textbf{Group}: Metabolite Name & Subgroup & \textit{P} Value & \textit{q} Value & log\textsubscript{2}(FC) & \textit{m/z} & RT (s) & Column/ESI & Adduct & KEGG ID & CID & HMDB ID\\
\midrule[0.5pt]
\endfirsthead
\multicolumn{12}{@{}l}{\textit{(continued)}}\\
\toprule[0.5pt]
\textbf{Group}: Metabolite Name & Subgroup & \textit{P} Value & \textit{q} Value & log\textsubscript{2}(FC) & \textit{m/z} & RT (s) & Column/ESI & Adduct & KEGG ID & CID & HMDB ID\\
\midrule[0.5pt]
\endhead

\bottomrule
\endfoot
\bottomrule
\endlastfoot
\textbf{Nucleotide Flux} &  &  &  &  &  &  &  &  &  &  & \\
\textbf{GMP} & Purine Metabolism & 1.8E-8 & 4.1E-5 & 2.35 & 364.0646 & 242 & C18- & M+H & C00144 & 135398631 & HMDB0001397\\
\textbf{AMP} & Purine Metabolism & 4.8E-5 & 0.024 & 1.51 & 346.0557 & 18 & C18- & M-H & C00020 & 6083 & HMDB0000045\\
\textbf{Uracil} & Pyrimidine Metabolism & 1.3E-4 & 0.029 & 1.05 & 111.02 & 22 & C18- & M-H & C00106 & 1174 & HMDB0000300\\
\textbf{Uracil} & Pyrimidine Metabolism & 2.4E-4 & 0.036 & 1.53 & 113.0346 & 41 & C18- & M+H & C00106 & 1174 & HMDB0000300\\
\addlinespace
\textbf{Cytosine} & Pyrimidine Metabolism & 0.003 & 0.128 & 1.10 & 112.0507 & 38 & C18- & M+H & C00380 & 597 & HMDB0000630\\
2-Methylaminoadenosine & tRNA/Modified Nucleosides & 0.003 & 0.135 & 1.88 & 261.1085 & 61 & C18- & M+H-2H2O & C03218 & 439946 & –\\
2'-Deoxyinosine 5'-phosphate (dIMP) & Purine Catabolism & 0.004 & 0.146 & 1.40 & 333.0605 & 68 & C18- & M+H & C06196 & 135398614 & HMDB0006555\\
\textbf{Guanine} & Purine Salvage & 0.011 & 0.241 & 0.75 & 150.0424 & 23 & C18- & M-H & C00242 & 135398634 & HMDB0000132\\
\textbf{Ribose 5-phosphate} & Pentose Phosphate Path & 0.014 & 0.254 & 2.42 & 231.0262 & 160 & C18- & M+H & C00117 & 439167 & –\\
\addlinespace
\textbf{CTP} & Pyrimidine Metabolism & 0.015 & 0.264 & 1.28 & 517.955 & 52 & C18- & M+Cl & C00063 & 6176 & HMDB0000082\\
5-Aminoimidazole & Purine Biosynthesis & 0.031 & 0.335 & 1.05 & 128.0193 & 92 & C18- & M+2Na-H & C05239 & 484 & HMDB0003929\\
\textbf{dATP} & DNA Precursor & 0.043 & 0.367 & -0.92 & 557.9782 & 285 & C18- & M-H+HCOONa & C00131 & 15993 & HMDB0001532\\
 &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Protein/AA Turnover} &  &  &  &  &  &  &  &  &  &  & \\
\addlinespace
\textbf{Iminoaspartate} & Aspartate Metabolism & 5.0E-5 & 0.024 & 1.80 & 96.0081 & 27 & C18- & M+H-2H2O & C05840 & 796 & HMDB0001131\\
3-Methylcrotonylglycine & Amino Acid/Leucine Branch & 0.002 & 0.124 & 1.06 & 158.081 & 75 & C18- & M+H & C20828 & 169485 & –\\
\textbf{Imidazole acetaldehyde} & Histidine Catabolism & 0.002 & 0.126 & 1.25 & 111.0554 & 71 & C18- & M+H & C05130 & 150841 & HMDB0003905\\
\textbf{delta-Guanidinovaleric acid (δ-GVA)} & Arginine Catabolism & 0.003 & 0.128 & 1.61 & 182.0908 & 54 & C18- & M+Na & C13688 & 160464 & HMDB0250978\\
2-Oxobutanoate & Methionine/Cysteine Catabolism & 0.004 & 0.159 & 0.64 & 101.0244 & 22 & C18- & M-H & C00109 & 58 & HMDB0000005\\
\addlinespace
4-Methylthio-2-oxobutanoic acid (MTOB) & Methionine Salvage & 0.007 & 0.198 & 0.96 & 149.0266 & 74 & C18- & M+H & C01180 & 473 & HMDB0001553\\
\textbf{Aspartate} & Central AA Metabolism & 0.007 & 0.198 & 1.11 & 134.0448 & 67 & C18- & M+H & C00049 & 5960 & HMDB0000191\\
\textbf{Histidine} & Essential AA Pool & 0.008 & 0.205 & 0.98 & 156.0767 & 75 & C18- & M+H & C00135 & 6274 & HMDB0000177\\
\textbf{Asparagine} & Nitrogen Salvage & 0.011 & 0.235 & 1.02 & 133.0607 & 76 & C18- & M+H & C00152 & 6267 & HMDB0000168\\
\textbf{Citrulline} & Urea Cycle/NO Signaling & 0.016 & 0.279 & 0.94 & 174.0885 & 20 & C18- & M-H & C00327 & 9750 & HMDB0000904\\
\addlinespace
\textbf{N6-Hydroxy-lysine} & Modified Lysine/Hydroxylation & 0.017 & 0.279 & 1.94 & 163.1077 & 113 & C18- & M+H & C01028 & 439370 & –\\
\textbf{Phenol} & Tyrosine Catabolism & 0.018 & 0.279 & 0.85 & 95.0493 & 51 & C18- & M+H & C00146 & 996 & –\\
\textbf{S-Allyl-cysteine} & Sulfur Amino Acids & 0.021 & 0.291 & 1.31 & 206.0213 & 232 & C18- & M+2Na-H & C16759 & 9793905 & HMDB0034323\\
β-Alanyl-lysine & Dipeptide/Autophagy & 0.025 & 0.311 & 1.58 & 218.1499 & 64 & C18- & M+H & C05341 & 440638 & HMDB0060442\\
\textbf{Imidazole acetaldehyde} & Histidine Catabolism & 0.025 & 0.313 & 0.28 & 169.0619 & 17 & C18- & M+Hac-H & C05130 & 150841 & HMDB0003905\\
\addlinespace
4-Guanidinobutanal & Arginine/Putrescine Path & 0.027 & 0.320 & 0.93 & 152.0787 & 228 & C18- & M+Na & C02647 & 559 & –\\
\textbf{Pipecolate} & Lysine Catabolism & 0.029 & 0.330 & 1.02 & 130.0862 & 71 & C18- & M+H & C00408 & 439227 & HMDB0000070\\
\textbf{Leucyl-leucine} & Dipeptide/Autophagy & 0.030 & 0.330 & 2.22 & 245.1859 & 26 & C18- & M+H & C11332 & 94244 & HMDB0028933\\
4-Imidazolone-5-acetate & Histidine Catabolism & 0.035 & 0.345 & 0.35 & 187.0358 & 179 & C18- & M+FA-H & C05133 & 440570 & –\\
\textbf{Dehydroalanine} & Post-Translational Modification & 0.035 & 0.345 & 0.93 & 88.0394 & 65 & C18- & M+H & C02218 & 123991 & HMDB0003609\\
\addlinespace
2-Amino-6-oxoheptanedioate & Lysine Metabolism & 0.035 & 0.345 & -0.71 & 190.0711 & 233 & C18- & M+H & C03871 & 194695 & –\\
\textbf{N6-Acetyl-lysine} & Protein Acetylation & 0.038 & 0.356 & 1.32 & 189.1233 & 47 & C18- & M+H & C02727 & 92832 & HMDB0000206\\
\textbf{Methylguanidine} & Arginine/Creatine Path & 0.039 & 0.357 & 0.63 & 118.035 & 91 & C18- & M+2Na-H & C02294 & 10111 & HMDB0001522\\
\textbf{O-Succinyl-homoserine} & Methionine Metabolism & 0.040 & 0.357 & 1.78 & 220.0816 & 66 & C18- & M+H & C01118 & 439406 & –\\
\textbf{Lysine} & Essential AA Pool & 0.040 & 0.357 & 0.96 & 147.1128 & 75 & C18- & M+H & C00047 & 5962 & HMDB0000182\\
\addlinespace
\textbf{D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate (IGP)} & Histidine Biosynthesis & 0.041 & 0.359 & 1.36 & 283.0072 & 50 & C18- & M+2Na-H & C04666 & 440431 & HMDB0012208\\
\textbf{Pipecolate} & Lysine Catabolism & 0.048 & 0.388 & 0.54 & 128.0718 & 23 & C18- & M-H & C00408 & 439227 & HMDB0000070\\
\textbf{Phenylacetylglutamine} & Phenylalanine/Gut Microbiome & 0.048 & 0.388 & 1.20 & 263.104 & 22 & C18- & M-H & C04148 & 92258 & HMDB0006344\\
 &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Membrane Integrity} &  &  &  &  &  &  &  &  &  &  & \\
\addlinespace
3-Ketosphingosine & Sphingosine Synthesis & 7.4E-5 & 0.028 & 2.70 & 298.2741 & 24 & C18- & M+H & C06121 & 9839212 & –\\
3-Dehydrosphinganine & Sphingosine Synthesis & 2.0E-4 & 0.033 & 3.38 & 300.2897 & 24 & C18- & M+H & C02934 & 439853 & HMDB0001480\\
\textbf{Oleoylglycerone phosphate (Oleoyl-DHAP)} & Plasmalogen Precursor & 0.002 & 0.123 & 1.84 & 433.2365 & 166 & C18- & M-H & C03630 & 5280612 & –\\
\textbf{sn-Glycero-3-phospho-1-inositol (GroPIns)} & PI-Signaling Byproduct & 0.014 & 0.261 & 2.18 & 333.0593 & 147 & C18- & M-H & C01225 & 45480545 & HMDB0011649\\
\textbf{Phosphodimethylethanolamine} & Membrane Synthesis/Methylation & 0.014 & 0.263 & 0.71 & 192.0397 & 42 & C18- & M+Na & C13482 & 151438 & HMDB0060236\\
\addlinespace
 &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Lipid Remodeling} &  &  &  &  &  &  &  &  &  &  & \\
(6Z,9Z,12Z)-Octadecatrienoic acid (γ-Linolenate) & Linolenic Acid Path & 1.1E-4 & 0.028 & 2.47 & 279.232 & 24 & C18- & M+H & C06426 & 5280933 & HMDB0003073\\
\textbf{Linoleate} & Essential Fatty Acids & 0.002 & 0.118 & 2.53 & 281.2476 & 29 & C18- & M+H & C01595 & 5280450 & HMDB0000673\\
9-Hydroxy-12-oxo-octadecadienoate & Oxylipin Path & 0.004 & 0.145 & 1.37 & 309.207 & 222 & C18- & M-H & C21923 & 45934096 & –\\
\addlinespace
(9Z)-Hexadecenoic acid (Palmitoleate) & Monounsaturated Fatty Acids & 0.004 & 0.146 & 1.60 & 253.2173 & 213 & C18- & M-H & C08362 & 445638 & HMDB0003229\\
(9Z)-Octadecenoic acid (Oleate) & Monounsaturated Fatty Acids & 0.004 & 0.161 & 2.28 & 283.2633 & 29 & C18- & M+H & C00712 & 445639 & HMDB0000207\\
16-Hydroxypalmitate & Omega-Oxidation & 0.008 & 0.205 & 0.29 & 271.2279 & 148 & C18- & M-H & C18218 & 10466 & HMDB0006294\\
\textbf{Stearidonic acid (Stearidonate)} & Omega-3 Metabolism & 0.010 & 0.235 & 1.55 & 277.2163 & 23 & C18- & M+H & C16300 & 5312508 & HMDB0006547\\
\textbf{Dodecanoic acid (Laurate)} & Medium-Chain Fatty Acids & 0.012 & 0.244 & 0.85 & 199.1703 & 156 & C18- & M-H & C02679 & 3893 & HMDB0000638\\
\addlinespace
\textbf{Tetradecanoic acid (Myristate)} & Saturated Fatty Acids & 0.017 & 0.279 & 1.09 & 227.2017 & 200 & C18- & M-H & C06424 & 11005 & HMDB0000806\\
\textbf{Decanoic acid (Caprate)} & Medium-Chain Fatty Acids & 0.018 & 0.279 & 0.74 & 171.139 & 107 & C18- & M-H & C01571 & 2969 & HMDB0000511\\
\textbf{Dihomo-γ-linolenate} & Prostanoid Precursors & 0.018 & 0.279 & 2.28 & 307.2633 & 24 & C18- & M+H & C03242 & 5280581 & HMDB0002925\\
\textbf{Octadecanoic acid (Stearate)} & Saturated Fatty Acids & 0.023 & 0.303 & 1.58 & 285.2789 & 19 & C18- & M+H & C01530 & 5281 & HMDB0000827\\
9,10-Epoxystearate* & Oxylipin Path & 0.024 & 0.307 & 0.77 & 297.2437 & 252 & C18- & M-H & C19418 & 15868 & HMDB0247617\\
\addlinespace
\textbf{Erucic acid (Erucate)} & Very-Long-Chain Fatty Acids & 0.024 & 0.311 & 1.29 & 397.3324 & 289 & C18- & M+Hac-H & C08316 & 5281116 & HMDB0002068\\
1-Dodecanol & Fatty Alcohols & 0.032 & 0.337 & 2.16 & 231.1702 & 29 & C18- & M+2Na-H & C02277 & 8193 & HMDB0011626\\
3-Hydroxytetradecane-tricarboxylate & Lipid Metabolism & 0.035 & 0.345 & 1.74 & 369.1871 & 64 & C18- & M+Na & C04529 & 5460247 & –\\
(6Z,9Z,12Z)-Octadecatrienoic acid (γ-Linolenate) & Linolenic Acid Path & 0.037 & 0.355 & 1.11 & 277.2173 & 201 & C18- & M-H & C06426 & 5280933 & HMDB0003073\\
(9Z)-Octadecenoic acid (Oleate) & Monounsaturated Fatty Acids & 0.039 & 0.357 & 1.11 & 281.2486 & 250 & C18- & M-H & C00712 & 445639 & HMDB0000207\\
\addlinespace
\textbf{Hexadecanoic acid (Palmitate)} & Saturated Fatty Acids & 0.040 & 0.357 & 0.47 & 255.2328 & 243 & C18- & M-H & C00249 & 985 & HMDB0000220\\
9,10-Epoxystearate* & Oxylipin Path & 0.047 & 0.385 & 0.90 & 299.2582 & 31 & C18- & M+H & C19418 & 15868 & HMDB0247617\\
16-Oxopalmitate & Omega-Oxidation & 0.048 & 0.388 & 0.42 & 271.2268 & 23 & C18- & M+H & C19614 & 15931626 & –\\
 &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Epigenetic Signaling} &  &  &  &  &  &  &  &  &  &  & \\
\addlinespace
\textbf{S-Adenosyl-L-homocysteine (SAH)} & Methylation Cycle Marker & 2.9E-4 & 0.039 & 1.70 & 385.128 & 73 & C18- & M+H & C00021 & 439155 & HMDB0000939\\
\textbf{Acetylglutamate} & Urea Cycle Regulation & 9.4E-4 & 0.076 & 1.29 & 188.0565 & 17 & C18- & M-H & C00624 & 70914 & HMDB0001138\\
8-Amino-7-oxononanoate & Biotin (B7) Metabolism & 0.001 & 0.094 & 2.03 & 188.1281 & 40 & C18- & M+H & C01092 & 173 & HMDB0240687\\
3'-Phosphoadenylyl sulfate (PAPS) & Universal Sulfate Donor & 0.002 & 0.115 & 2.22 & 573.9672 & 23 & C18- & M-H+HCOONa & C00053 & 10214 & HMDB0001134\\
\textbf{Formate} & Folate Cycle Entry & 0.003 & 0.135 & 1.09 & 90.9768 & 53 & C18- & M+2Na-H & C00058 & 284 & HMDB0000142\\
\addlinespace
1-Methylnicotinamide & Nicotinate/Nicotinamide Path & 0.008 & 0.205 & 2.86 & 137.071 & 47 & C18- & M+H & C02918 & 457 & HMDB0000699\\
5-Methylcytosine & Epigenetic DNA Modification & 0.019 & 0.283 & 0.39 & 124.0515 & 225 & C18- & M-H & C02376 & 65040 & HMDB0002894\\
\textbf{Maleamate} & Nicotinate Metabolism & 0.023 & 0.303 & 0.81 & 114.0197 & 17 & C18- & M-H & C01596 & 5280451 & –\\
8-Amino-7-carboxyamino-nonanoate & Biotin (B7) Metabolism & 0.023 & 0.303 & 1.65 & 197.1282 & 44 & C18- & M+H-2H2O & C22458 & 4474067 & –\\
\textbf{Nicotinurate} & Nicotinate/Nicotinamide Path & 0.026 & 0.320 & 0.51 & 181.0608 & 238 & C18- & M+H & C05380 & 68499 & HMDB0003269\\
\addlinespace
\textbf{Choline} & Methyl Donor/Phospholipids & 0.027 & 0.320 & 1.25 & 104.1071 & 36 & C18- & M+H & C00114 & 305 & HMDB0000097\\
\textbf{N6-Methyl-lysine} & Histone Methylation & 0.030 & 0.330 & 1.01 & 161.1285 & 67 & C18- & M+H & C02728 & 164795 & HMDB0002038\\
\textbf{Choline} & Methyl Donor/Phospholipids & 0.037 & 0.355 & 1.05 & 170.0799 & 26 & C18- & M-H+HCOONa & C00114 & 305 & HMDB0000097\\
\textbf{Nicotinamide} & NAD+ Precursor & 0.038 & 0.356 & 1.81 & 123.0553 & 34 & C18- & M+H & C00153 & 936 & HMDB0001406\\
 &  &  &  &  &  &  &  &  &  &  & \\
\addlinespace
\textbf{Steroid Metabolism} &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Pregnan-21-al} & Progestogen Metabolism & 4.4E-4 & 0.050 & 2.12 & 347.2604 & 175 & C18- & M+FA-H & C00891 & 439338 & –\\
11-cis-Retinol & Vitamin A/Retinoids & 0.008 & 0.202 & 2.90 & 287.237 & 25 & C18- & M+H & C00899 & 5280382 & HMDB0006216\\
\textbf{Phenolic steroid} & Estrogen-like Compounds & 0.013 & 0.254 & 2.61 & 279.1712 & 34 & C18- & M+Na & C02453 & 439726 & HMDB0244763\\
7-Dehydrocholesterol (7-DHC) & Cholesterol Precursor & 0.020 & 0.291 & 3.39 & 385.3466 & 23 & C18- & M+H & C01164 & 439423 & HMDB0000032\\
\addlinespace
\textbf{Estrone} & Estrogens & 0.030 & 0.330 & 1.40 & 271.1682 & 252 & C18- & M+H & C00468 & 5870 & HMDB0000145\\
19-Norprogesterone & Progestogen Metabolism & 0.036 & 0.350 & 2.04 & 345.1788 & 67 & C18- & M+2Na-H & C14489 & 228864 & –\\
\textbf{Estradiol-17β} & Estrogens & 0.038 & 0.356 & 2.53 & 295.1661 & 39 & C18- & M+Na & C00951 & 5757 & HMDB0000151\\
\textbf{Cortolone} & Cortisol Catabolism & 0.049 & 0.388 & -1.43 & 365.2332 & 161 & C18- & M-H & C05481 & 160499 & HMDB0003128\\
 &  &  &  &  &  &  &  &  &  &  & \\
\addlinespace
\textbf{Redox Homeostasis} &  &  &  &  &  &  &  &  &  &  & \\
6-Carboxytetrahydropterin & Biopterin Cycle/Redox & 5.4E-4 & 0.053 & 2.20 & 195.0514 & 212 & C18- & M+H-NH3 & C20239 & 135911925 & HMDB0060410\\
\textbf{Dihydroneopterin} & Biopterin Cycle/Redox & 8.3E-4 & 0.073 & 3.43 & 256.1043 & 61 & C18- & M+H & C04874 & 135398602 & HMDB0002275\\
\textbf{Tetrahydropteridine} & Biopterin Cycle/Redox & 0.001 & 0.077 & 1.47 & 137.0822 & 225 & C18- & M+H & C05650 & 156 & HMDB0001216\\
2-(Hydroxysulfanyl)hercynine (HSH-Hercynine) & Ergothioneine Precursor & 0.005 & 0.174 & 1.54 & 246.0907 & 66 & C18- & M+H & C21731 & 122706276 & –\\
\addlinespace
\textbf{Cysteate} & Cysteine Metabolism & 0.012 & 0.244 & 1.87 & 170.0122 & 132 & C18- & M+H & C00506 & 72886 & HMDB0002757\\
\textbf{Hercynine} & Histidine/Redox Signaling & 0.020 & 0.289 & 1.20 & 198.1237 & 67 & C18- & M+H & C05575 & 440727 & HMDB0029422\\
3-Bromo-tyrosine & Oxidative Protein Damage & 0.027 & 0.320 & 0.59 & 303.9817 & 51 & C18- & M+FA-H & C17079 & 148708 & HMDB0005874\\
\textbf{DH-Monapterin triphosphate} & Biopterin Cycle/Redox & 0.037 & 0.355 & 1.62 & 459.9838 & 167 & C18- & M+H-2H2O & C21094 & 135398606 & –\\
 &  &  &  &  &  &  &  &  &  &  & \\
\addlinespace
\textbf{Fatty Acid Oxidation} &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Isovalerylcarnitine} & Acylcarnitine Shuttle & 0.002 & 0.126 & 2.67 & 246.1699 & 30 & C18- & M+H & C20826 & 169235 & –\\
\textbf{Butanoylcarnitine} & Acylcarnitine Shuttle & 0.004 & 0.153 & 2.72 & 232.1543 & 33 & C18- & M+H & C02862 & 439829 & HMDB0002013\\
\textbf{Carnitinamide} & Acylcarnitine-like & 0.015 & 0.264 & 1.80 & 143.1179 & 35 & C18- & M+H-H2O & C02290 & 11701090 & –\\
\textbf{Carnitine} & Fatty Acid Transport & 0.039 & 0.357 & 1.28 & 162.1125 & 46 & C18- & M+H & C00318 & 10917 & HMDB0000062\\
\addlinespace
\textbf{Decanoylcarnitine} & Acylcarnitine Shuttle & 0.041 & 0.359 & 1.14 & 360.2389 & 154 & C18- & M+FA-H & C03299 & 11953821 & HMDB0000651\\
 &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Bioenergetic Flux} &  &  &  &  &  &  &  &  &  &  & \\
(2,3-Dihydroxybenzoyl)adenylate (2,3-DHBA-AMP) & Iron Scavenging/Siderophore & 0.003 & 0.130 & 2.37 & 506.0677 & 261 & C18- & M+Na & C04030 & 440201 & –\\
2,3-Dihydroxybenzoate & Iron-Binding/Catechols & 0.004 & 0.154 & -0.54 & 153.0194 & 22 & C18- & M-H & C00196 & 19 & HMDB0000397\\
\addlinespace
\textbf{D-4'-Phosphopantothenate (P-Pantothenate)} & Coenzyme A (CoA) Path & 0.005 & 0.161 & -1.04 & 300.0844 & 119 & C18- & M+H & C03492 & 41635 & HMDB0001016\\
4-Methyl-2-oxopentanoate (α-Ketoisocaproate) & Leucine Catabolism & 0.019 & 0.281 & -1.41 & 129.0558 & 23 & C18- & M-H & C00233 & 70 & HMDB0000695\\
5-(2-Hydroxyethyl)-4-methylthiazole (Sulfurol) & Thiamine (B1) Metabolism & 0.025 & 0.313 & 0.56 & 142.0339 & 186 & C18- & M-H & C04294 & 1136 & HMDB0032985\\
\textbf{Acetyl phosphate} & High-Energy Intermediate & 0.027 & 0.324 & -0.99 & 138.9802 & 24 & C18- & M-H & C00227 & 186 & HMDB0001494\\
5-Amino-6-ribitylaminouracil & Riboflavin (B2) Metabolism & 0.048 & 0.388 & 0.67 & 275.0996 & 20 & C18- & M-H & C04732 & 193516 & HMDB0011106\\
\addlinespace
 &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Glycan Defense} &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Chitobiose} & Glucosamine Metabolism & 0.003 & 0.135 & 1.75 & 459.14 & 20 & C18- & M+Cl & C01674 & 439544 & HMDB0003556\\
\textbf{N-Glycolyl-glucosamine} & Hexosamine Biosynthesis & 0.020 & 0.288 & 1.04 & 236.0777 & 16 & C18- & M-H & C03146 & 439921 & –\\
\textbf{N-Acetyl-9-O-acetylneuraminate (9-O-Acetyl-Neu5Ac)*} & Sialic Acid Modification & 0.025 & 0.313 & 1.52 & 410.1301 & 17 & C18- & M+Hac-H & C04017 & 92042744 & –\\
\addlinespace
 &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Immune/Signaling} &  &  &  &  &  &  &  &  &  &  & \\
\textbf{Serotonin} & Tryptophan Signaling & 0.005 & 0.174 & 3.76 & 177.1022 & 28 & C18- & M+H & C00780 & 5202 & HMDB0000259\\
\textbf{N1-Acetylspermine} & Polyamine Acetylation & 0.007 & 0.198 & 3.04 & 245.2335 & 257 & C18- & M+H & C02567 & 916 & HMDB0001186\\
\textbf{Kynurenine} & Tryptophan/Kynurenine Axis & 0.009 & 0.220 & 2.22 & 209.0921 & 42 & C18- & M+H & C00328 & 161166 & HMDB0000684\\
\addlinespace
3-Hydroxyaminophenol & Phenylalanine Branch & 0.011 & 0.239 & 0.62 & 126.055 & 86 & C18- & M+H & C14602 & 5460445 & –\\
\textbf{N1-Acetylspermidine} & Polyamine Acetylation & 0.016 & 0.276 & 1.36 & 188.1757 & 56 & C18- & M+H & C00612 & 496 & HMDB0001276\\
γ-Glutamyltyramine & Tyramine/Dopamine Path & 0.017 & 0.279 & 2.53 & 267.1343 & 32 & C18- & M+H & C20926 & 10214674 & –\\
\textbf{N-Methylhistamine} & Histamine Metabolism & 0.021 & 0.291 & 2.29 & 126.1026 & 60 & C18- & M+H & C05127 & 3614 & HMDB0000898\\
\textbf{Kynurenine} & Tryptophan/Kynurenine Axis & 0.022 & 0.303 & 1.41 & 207.0776 & 22 & C18- & M-H & C00328 & 161166 & HMDB0000684\\
\addlinespace
4-Carboxy-4-hydroxy-2-oxoadipate & Tryptophan/Anthranilate Path & 0.023 & 0.303 & 0.80 & 219.0146 & 24 & C18- & M-H & C04115 & 130 & –\\
2-Aminomuconate & Tryptophan/Kynurenine Axis & 0.027 & 0.320 & 1.18 & 158.0451 & 34 & C18- & M+H & C02220 & 5280499 & HMDB0001241\\
\textbf{Leukotriene D4 (LTD4)} & Leukotriene Synthesis & 0.031 & 0.335 & 1.22 & 555.2725 & 149 & C18- & M+Hac-H & C05951 & 5280878 & HMDB0003080\\
\textbf{Histamine} & Histidine/Immune Signaling & 0.033 & 0.345 & 1.44 & 112.0871 & 67 & C18- & M+H & C00388 & 774 & HMDB0000870\\
\textbf{Biliverdin} & Heme Degradation/Redox & 0.034 & 0.345 & 1.73 & 583.2547 & 31 & C18- & M+H & C00500 & 5280353 & HMDB0001008\\
\addlinespace
2-Aminomuconate semialdehyde & Tryptophan/Kynurenine Path & 0.034 & 0.345 & 0.31 & 142.0498 & 183 & C18- & M+H & C03824 & 5280625 & HMDB0001280\\
\textbf{Prostaglandin E2 (PGE2)} & COX-driven Inflammation & 0.035 & 0.345 & 0.83 & 411.2404 & 152 & C18- & M+Hac-H & C00584 & 5280360 & HMDB0001220\\
\textbf{Benzylamine} & Monoamine Metabolism & 0.043 & 0.367 & 0.93 & 91.0544 & 42 & C18- & M+H-NH3 & C15562 & 7504 & HMDB0033871\\
\textbf{Leukotriene B4 (LTB4)*} & Leukotriene Synthesis & 0.043 & 0.368 & 1.31 & 335.2224 & 219 & C18- & M-H & C02165 & 5280492 & HMDB0001085\\
\textbf{Adrenaline} & Catecholamine Signaling & 0.044 & 0.370 & -0.55 & 242.1045 & 239 & C18- & M+Hac-H & C00788 & 5816 & HMDB0000068\\
\addlinespace
5,6-Indolequinone-2-carboxylate & Melanogenesis/Dopa Path & 0.048 & 0.388 & 1.49 & 235.9932 & 36 & C18- & M+2Na-H & C17938 & 17796835 & –\\
2'-Phospho-cyclic ADP-ribose (2'-P-cADPR) & Calcium Signaling & 0.049 & 0.388 & 1.57 & 622.0327 & 268 & C18- & M+H & C20742 & 73352906 & –\\
\textbf{N-Methyltryptamine} & Tryptophan/Indole Signaling & 0.050 & 0.388 & 1.05 & 175.1234 & 70 & C18- & M+H & C06213 & 6088 & HMDB0004370\\*
\end{longtable}
\endgroup{}
